Who Owns Actuate Therapeutics Stock?
NASDAQ: ACTUHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 56.29%
- Held by insiders
- 15.41%
- Institutional holders
- 74
- Institutions 56.3%
- Insiders 15.4%
- Public and other 28.3%
Who owns Actuate Therapeutics stock?
Institutional investors own about 56.3% of Actuate Therapeutics's shares, spread across 74 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 15.41% of ACTU.
The largest institutional holders are Bios Capital Management, LP (41.85%), Voss Capital, LP (7.18%) and Vanguard Capital Management LLC (1.64%). Together, the top 10 institutions control 53.6% of shares outstanding. In their latest filings, 4 of the top 10 institutions increased their ACTU positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of ACTU
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Bios Capital Management, LP | 10.05M | 41.85% | 0.0% |
| Voss Capital, LP | 1.73M | 7.18% | 0.0% |
| Vanguard Capital Management LLC | 393.43K | 1.64% | -1.8% |
| AQR Capital Management, LLC | 127.49K | 0.53% | +370.3% |
| Geode Capital Management, LLC | 112.55K | 0.47% | -50.7% |
| Texas Capital Bank Wealth Management Services, Inc. | 102.61K | 0.43% | +8.5% |
| Palogic Value Management, LP | 100.00K | 0.42% | 0.0% |
| Millennium Management Llc | 96.68K | 0.40% | +100.0% |
| Blackrock Inc. | 90.03K | 0.37% | -78.9% |
| Abs Investment Management LLC | 73.19K | 0.30% | +100.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of ACTU
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 287.38K | 1.20% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 106.05K | 0.44% |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | 48.40K | 0.20% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 47.85K | 0.20% |
| iShares Trust-iShares Micro-Cap ETF | 37.98K | 0.16% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 20.31K | 0.08% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 13.59K | 0.06% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 12.25K | 0.05% |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Growth Index Fund | 8.85K | 0.04% |
| VALIC Co I-Small Cap Index Fund | 5.49K | 0.02% |
Frequently asked questions
Who is the largest shareholder of Actuate Therapeutics?
Bios Capital Management, LP is the largest institutional shareholder of ACTU, owning 41.85% of shares outstanding (10.05M shares) as of its latest 13F filing.
What percentage of Actuate Therapeutics is owned by institutions?
Institutions own about 56.3% of ACTU shares and 66.5% of the public float.
How much of Actuate Therapeutics do insiders own?
Insiders, such as officers and directors, own about 15.41% of ACTU shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.